Topical doxyl composition and method

Details Topical doxyl composition and method Topical doxyl composition and method

1995-06-05

1998-02-10

Lambkin, Deborah

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514374, A61K 3158, A61K 3142

Patent

active

057169470

ABSTRACT:
A composition and method for ameliorating a cellular dysfunction of a tissue such as the cosmetic treatment of hair loss and stimulation of hair growth is disclosed. The method comprises administering 2,2-disubstituted-4,4-dimethyl-3-oxazolidinyloxy (DOXYL) to the affected tissue.

REFERENCES:
patent: 2409754 (1946-10-01), Henze
patent: 2986573 (1961-05-01), Topliss
patent: 3257390 (1966-06-01), Patchett
patent: 3461461 (1969-08-01), Anthony et al.
patent: 3527864 (1970-09-01), MacMillen et al.
patent: 3551554 (1970-12-01), Herschler
patent: 3896238 (1975-07-01), Smith
patent: 4139619 (1979-02-01), Chidsey, III
patent: 4184039 (1980-01-01), Soldati
patent: 4254145 (1981-03-01), Birnbaum
patent: 4344941 (1982-08-01), Wiechert
patent: 4347245 (1982-08-01), Shapiro
patent: 4367227 (1983-01-01), Bingham
patent: 4444762 (1984-04-01), Rajadhyaksha
patent: 4456600 (1984-06-01), Wiechert
Anderson, Chemical Abstracts, vol. 90, pp. 311K (1979).
Ando et al., Chemical Abstracts, 93:79872n (1980).
Bazzano et al., Journal of American Academy of Dermatology, vol. 15, pp. 880-883 (1986).
Berry, Pharmacology of the Skin, vol. 1, pp. 121-137 (1987).
Cheng et al., Archives of Dermatological Research, vol. 278, pp. 470-473 (1986).
Cumming et al., Journal of American Medical Association, vol. 247, pp. 1295-1298 (1982).
Current Therapy, pp. 599-603 (1984).
Dahl, Men's Fitness, pp. 93-95 (Feb. 1989).
Dawber, Dermatologica, vol. 175, suppl. 2, pp. 23-28 (1987).
DeVillez, Archives of Dermatology, vol. 121, pp. 197-202, (1985).
Dermatologica, vol. 175, suppl. 2, pp. 1-56 (Oct. 87).
Dostert et al., Xenobiotica, vol. 15, No. 10, pp. 799-803 (1985).
Ehman et al., Investigative Radiology, vol. 21, pp. 125-131 (1986).
Feelisch et al., Evr. Journal of Pharmacology, vol. 139, pp. 19-30 (1987).
Feelisch et al., Evr. Journal of Pharmacology, vol. 142, pp. 405-409 (1987).
Fiedler, Dermatologica, vol. 175, suppl. 2, pp. 29-35 (1987).
Fox et al., Annals of the New York Academy of Sciences, vol. 411, pp. 14-19 (1983).
Goffman et al., International Journal of Radiation, Oncology, Biology and Physics, vol. 22, pp. 803-806 (Nov. 4, 1992).
Headington, Current Therapeutic Research, vol. 36, pp. 1098-1105 (1984).
Hearse et al., Circulation Research, vol. 60, pp. 375-383 (1987).
Herschler, Chemical Abstracts, vol. 78, pp. 115239 (1973).
Ignarro et al., Biochemica et. Biophysica Acta, vol. 631, pp. 221-231 (1980).
J., Soc. Cosmetology Chem., (Italy) vol. 33, pp. 95-96 (Mar./Apr. 1982).
Journal of American Medical Association, vol. 260, No. 20 (1988).
Karlsson et al., Journal of Cyclic Nucleotide and Protein Res., vol. 10, No. 4, pp. 309-315 (1985).
Kvedar, Journal of American Academic Dermatology, vol. 12, pp. 215-225 (1985).
Longevity, vol. 2, No. 3, p. 26 (Jan. 1988).
Lucky, Archives of Dermatology, vol. 121, pp. 57-62 (1985).
Messina, Current Therapeutic Research, vol. 34, pp. 319-324 (1983).
Messina, Current Therapeutic Research, vol. 38, pp. 269-282 (1985).
Mitchell et al., IBC USA Conference, South Natick, MA (Jun. 27, 1991).
Mittal et al., Proc. of National Academy of Science, USA, vol. 74, No. 10, pp. 4360-4364 (1977).
Palmer et al., Nature, vol. 327, pp. 524-526 (Jun. 11, 1987).
Parrett et al. Journal of Pharmacology, vol. 91, pp. 49-59 (1987).
Physician's Desk Reference, pp. 883, 997-978, 1782-1785, 1961 (1983).
Proctor et al., Physiological Chemistry and Physics in Medical NMR, vol. 16, pp. 175-195 (1984).
Ross, U.S. Department of Commerce, National Bureau of Standards, Publication NSRDS-NBS59 (Jan. 1977).
Sekura, Advances of Biology and Skin, vol. XII, pp. 257-269, (1972).
Shapiro et al., Journal of Clinical Endocrinology and Metabolism, vol. 51, pp. 429-430 (1980).
Stewart, International Journal of Dermatology, vol. 17, pp. 167-179 (1978).
Thompson, Federal Drug Administration Consumer, pp. 10 and 12 (Mar. 10, 1981).
Tiffany-Castiglion, Biochemical Pharmacology, vol. 31, No. 2, pp. 181-188 (1982).
Torre (Ed.), Annals of the New York Academy of Sciences, vol. 411, Table of Contents (1983).
Vermorken, Acta Dermatovener (Stockholm), vol. 63, pp. 268-269 (1982).

Affiliated with

Also associated with

Rating

Topical doxyl composition and method does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Topical doxyl composition and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical doxyl composition and method will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2077490